Ornithine decarboxylase attenuates leukemic chemotherapy drugs-induced cell apoptosis and arrest in human promyelocytic HL-60 cells

Leukemia Research

Volumn 32, Issue 10, 2008, Pages 1530-1540

  Hsu, Pei Chen ^a,b   Hung, Hui Chih ^a   Liao, Ya Fan ^a   Liu, Chu Chen ^c   Tsay, Gregory J ^c   Liu, Guang Yaw ^c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b Da Chien General Hospital   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cancer chemotherapeutic drug; Cell cycle; Ornithine decarboxylase

Indexed keywords

ACETYLCYSTEINE; CASPASE; CISPLATIN; CYCLIN A; CYCLIN D; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; CYTOCHROME C; ETOPOSIDE; GLUTATHIONE; ORNITHINE DECARBOXYLASE; PACLITAXEL; PROTEIN BCL 2; PUTRESCINE; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCYSTEINE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL CYCLE; CISPLATIN; ETOPOSIDE; GLUTATHIONE; HL-60 CELLS; HUMANS; LEUKEMIA; MEMBRANE POTENTIAL, MITOCHONDRIAL; ORNITHINE DECARBOXYLASE; PACLITAXEL; PROTO-ONCOGENE PROTEINS C-BCL-2; PUTRESCINE; REACTIVE OXYGEN SPECIES;

EID: 44649152084     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.01.017     Document Type: Article

References (63)

1. Tabor C.W., Tabor H., and Polyamines. Annu Rev Biochem 53 (1984) 749-790
2. Thomas T., and Thomas T.J. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 58 (2001) 244-258
3. Moshier J.A., Dosescu J., Skunca M., and Luk G.D. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res 53 (1993) 2618-2622
4. Auvinen M., Laine A., Paasinen-Sohns A., Kangas A., Kangas L., Saksela O., et al. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res 57 (1997) 3016-3025
5. Clifford A., Morgan D., Yuspa S.H., Soler A.P., and Gilmour S. Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res 55 (1995) 1680-1686
6. Smith M.K., Trempus C.S., and Gilmour S.K. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin. Carcinogenesis 19 (1998) 1409-1415
7. Persson L., and Rosengren E. Increased formation of N1-acetylspermidine in human breast cancer. Cancer Lett 45 (1989) 83-86
8. Canizares F., Salinas J., de las Heras M., Diaz J., Tovar I., Martinez P., et al. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. Clin Cancer Res 5 (1999) 2035-2041
9. Glikman P., Vegh I., Pollina M.A., Mosto A.H., and Levy C.M. Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer. Cancer 60 (1987) 2237-2243
10. Manni A., Mauger D., Gimotty P., and Badger B. Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. Clin Cancer Res 2 (1996) 1901-1906
11. Quemener V., Moulinoux J.P., Havouis R., and Seiler N. Polyamine deprivation enhances antitumoral efficacy of chemotherapy. Anticancer Res 12 (1992) 1447-1453
12. Fuller D.J., Gerner E.W., and Russell D.H. Polyamine biosynthesis and accumulation during the G1 to S phase transition. J Cell Physiol 93 (1977) 81-88
13. Kaczmarek L., Calabretta B., Ferrari S., and de Riel J.K. Cell-cycle-dependent expression of human ornithine decarboxylase. J Cell Physiol 132 (1987) 545-551
14. Rupniak H.T., and Paul D. Inhibition of spermidine and spermine synthesis leads to growth arrest of rat embryo fibroblasts in G1. J Cell Physiol 94 (1978) 161-170
15. Kramer D.L., Fogel-Petrovic M., Diegelman P., Cooley J.M., Bernacki R.J., McManis J.S., et al. Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells. Cancer Res 57 (1997) 5521-5527
16. Laitinen J., Stenius K., Eloranta T.O., and Holtta E. Polyamines may regulate S-phase progression but not the dynamic changes of chromatin during the cell cycle. J Cell Biochem 68 (1998) 200-212
17. Gallo C.J., Koza R.A., and Herbst E.J. Polyamines and HeLa-cell DNA replication. Biochem J 238 (1986) 37-42
18. Pohjanpelto P., Nordling S., and Knuutila S. Flow cytometric analysis of the cell cycle in polyamine-depleted cells. Cytometry 16 (1994) 331-338
19. Fredlund J.O., and Oredsson S.M. Impairment of DNA replication within one cell cycle after seeding of cells in the presence of a polyamine-biosynthesis inhibitor. Eur J Biochem 237 (1996) 539-544
20. Ploszaj T., Motyl T., Zimowska W., Skierski J., and Zwierzchowski L. Inhibition of ornithine decarboxylase by alpha-difluoromethylornithine induces apoptosis of HC11 mouse mammary epithelial cells. Amino Acids 19 (2000) 483-496
21. Park J.K., Chung Y.M., Kang S., Kim J.U., Kim Y.T., Kim H.J., et al. c-Myc exerts a protective function through ornithine decarboxylase against cellular insults. Mol Pharmacol 62 (2002) 1400-1408
22. Liu G.Y., Hung Y.C., Hsu P.C., Liao Y.F., Chang W.H., Tsay G.J., et al. Ornithine decarboxylase prevents tumor necrosis factor alpha-induced apoptosis by decreasing intracellular reactive oxygen species. Apoptosis 10 (2005) 569-581
23. Huang C.C., Hsu P.C., Hung Y.C., Liao Y.F., Liu C.C., Hour C.T., et al. Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production. Apoptosis 10 (2005) 895-907
24. Kao M.C., Liu G.Y., Chuang T.C., Lin Y.S., Wuu J.A., and Law S.L. The N-terminal 178-amino-acid domain only of the SV40 large T antigen acts as a transforming suppressor of the HER-2/neu oncogene. Oncogene 16 (1998) 547-554
25. Hour T.C., Chen L., and Lin J.K. Suppression of transcription factor NF-kappaB activity by Bcl-2 protein in NIH3T3 cells: implication of a novel NF-kappaB p50-Bcl-2 complex for the anti-apoptotic function of Bcl-2. Eur J Cell Biol 79 (2000) 121-129
26. Kunkel T.A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 82 (1985) 488-492
27. Liu G.Y., Chen K.J., Lin-Shiau S.Y., and Lin J.K. Peroxyacetyl nitrate-induced apoptosis through generation of reactive oxygen species in HL-60 cells. Mol Carcinog 25 (1999) 196-206
28. Amer J., Goldfarb A., and Fibach E. Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol 70 (2003) 84-90
29. Carter W.O., Narayanan P.K., and Robinson J.P. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 55 (1994) 253-258
30. Davis S., Weiss M.J., Wong J.R., Lampidis T.J., and Chen L.B. Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J Biol Chem 260 (1985) 13844-13850
31. 2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res 60 (2000) 3807-3812
32. Bertrand R., Solary E., Jenkins J., and Pommier Y. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Exp Cell Res 207 (1993) 388-397
33. Solary E., Bertrand R., and Pommier Y. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells. Leuk Lymphoma 15 (1994) 21-32
34. Facompre M., Wattez N., Kluza J., Lansiaux A., and Bailly C. Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide. Mol Cell Biol Res Commun 4 (2000) 37-42
35. Wani M.C., Taylor H.L., Wall M.E., Coggon P., and McPhail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93 (1971) 2325-2327
36. Schiff P.B., and Horwitz S.B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77 (1980) 1561-1565
37. Jordan M.A., and Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 10 (1998) 123-130
38. Jordan M.A., Toso R.J., Thrower D., and Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90 (1993) 9552-9556
39. Burns T.F., Fei P., Scata K.A., Dicker D.T., and El-Deiry W.S. Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells. Mol Cell Biol 23 (2003) 5556-5571
40. Fan S., Cherney B., Reinhold W., Rucker K., and O'Connor P.M. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment. Clin Cancer Res 4 (1998) 1047-1054
41. Wahl A.F., Donaldson K.L., Fairchild C., Lee F.Y., Foster S.A., Demers G.W., et al. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med 2 (1996) 72-79
42. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
43. Bouillet P., Purton J.F., Godfrey D.I., Zhang L.C., Coultas L., Puthalakath H., et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415 (2002) 922-926
44. Cory S., and Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2 (2002) 647-656
45. Puthalakath H., and Strasser A. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 9 (2002) 505-512
46. Li R., Moudgil T., Ross H.J., and Hu H.M. Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim. Cell Death Differ 12 (2005) 292-293
47. Cullen K.J., Yang Z., Schumaker L., and Guo Z. Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer. J Bioenerg Biomembr 39 (2007) 43-50
48. Eastman A., and Barry M.A. The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis?. Cancer Invest 10 (1992) 229-240
49. Eastman A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2 (1990) 275-280
50. Isonishi S., Saitou M., Yasuda M., and Tanaka T. Mitochondria in platinum resistant cells. Hum Cell 14 (2001) 203-210
51. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275 (1997) 1129-1132
52. Koza R.A., and Herbst E.J. Deficiencies in DNA replication and cell-cycle progression in polyamine-depleted HeLa cells. Biochem J 281 (1992) 87-93
53. Bergeron C.J., Basu H.S., Marton L.J., Deen D.F., Pellarin M., and Feuerstein B.G. Two polyamine analogs (BE-4-4-4 and BE-4-4-4-4) directly affect growth, survival, and cell cycle progression in two human brain tumor cell lines. Cancer Chemother Pharmacol 36 (1995) 411-417
54. Anehus S., Pohjanpelto P., Baldetorp B., Langstrom E., and Heby O. Polyamine starvation prolongs the S and G2 phases of polyamine-dependent (arginase-deficient) CHO cells. Mol Cell Biol 4 (1984) 915-922
55. Scorcioni F., Corti A., Davalli P., Astancolle S., and Bettuzzi S. Manipulation of the expression of regulatory genes of polyamine metabolism results in specific alterations of the cell-cycle progression. Biochem J 354 (2001) 217-223
56. Hu X., Washington S., Verderame M.F., and Manni A. Interaction between polyamines and the mitogen-activated protein kinase pathway in the regulation of cell cycle variables in breast cancer cells. Cancer Res 65 (2005) 11026-11033
57. Capell T., Bassie L., Topsom L., Hitchin E., and Christou P. Simultaneous reduction of the activity of two related enzymes, involved in early steps of the polyamine biosynthetic pathway, by a single antisense cDNA in transgenic rice. Mol Gen Genet 264 (2000) 470-476
58. Nitta T., Igarashi K., Yamashita A., Yamamoto M., and Yamamoto N. Involvement of polyamines in B cell receptor-mediated apoptosis: spermine functions as a negative modulator. Exp Cell Res 265 (2001) 174-183
59. Rosander U., Holm I., Grahn B., Lovtrup-Rein H., Mattsson M.O., and Heby O. Down-regulation of ornithine decarboxylase by an increased degradation of the enzyme during gastrulation of Xenopus laevis. Biochim Biophys Acta 1264 (1995) 121-128
60. Frostesjo L., and Heby O. Polyamine depletion up-regulates c-Myc expression, yet induces G(1) arrest and terminal differentiation of F9 teratocarcinoma stem cells. J Cell Biochem 76 (1999) 143-152
61. Stabellini G., Brugnoli F., Calastrini C., Vizzotto L., Vertemati M., Baroni T., et al. Ornithine decarboxylase, polyamines and CD11b expression in HL-60 cells during differentiation induced by retinoic acid. Biomed Pharmacother 58 (2004) 401-406
62. Liao YF, Hung HC, Hsu PC, Kao MC, Hour TC, Tsay GJ, et al. Ornithine decarboxylase interferes with macrophage-like differentiation and matrix metalloproteinase-9 expression by tumor necrosis factor alpha via NF-kappaB. Leuk Res 2008;32:1124-40.
63. Gilmour S.K., Birchler M., Smith M.K., Rayca K., and Mostochuk J. Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin. Cell Growth Differ 10 (1999) 739-748